| 臺大學術典藏 |
2022-05-11T08:25:41Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
Lin P.-H.; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; CHING-HUNG LIN; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; Wang M.-Y.; Lo C.; Lu Y.-S.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-15T05:39:30Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Lu Y.-S.; WEI-WU CHEN; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; Cheng A.-L.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2022-03-15T05:39:29Z |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu P.-F.; Lin C.-H.; Kuo C.-H.; WEI-WU CHEN; Yeh D.-C.; Liao H.-W.; Huang S.-M.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2022-03-15T05:39:25Z |
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer
|
WEI-WU CHEN; Yeh D.-C.; Chao T.-Y.; Lin C.-H.; Chow L.W.-C.; Chang D.-Y.; Hsieh Y.-Y.; Huang S.-M.; Cheng A.-L.; Lu Y.-S.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2022-03-10T02:31:33Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
PO-HAN LIN; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; Lin C.-H.; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; Wang M.-Y.; Lo C.; Lu Y.-S.; Huang C.-S. |
| 國立成功大學 |
2022 |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
Lin, P.-H.;Chen, S.-C.;Tseng, L.-M.;Chang, K.-J.;Huang, A.-C.;Cheng, K.-C.;Yang, K.;Wu, H.-C.;Chao, T.-Y.;Chang, Y.-C.;Lin, P.-C.;Kuo, W.-H.;Kuo, W.-L.;Lin, C.-H.;Chen, H.-M.;Yeh, D.-C.;Liu, Liu L.-C.;Liu, C.-Y.;Wang, M.-Y.;Lo, C.;Lu, Y.-S.;Huang, C.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu P.-F.; Lin C.-H.; Kuo C.-H.; Chen W.-W.; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; ANN-LII CHENG; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2021-08-31T06:29:30Z |
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer
|
Chen T.W.-W.; Yeh D.-C.; Chao T.-Y.; Lin C.-H.; Chow L.W.-C.; Chang D.-Y.; Hsieh Y.-Y.; Huang S.-M.; ANN-LII CHENG; Lu Y.-S.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2021-07-28T06:46:45Z |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu P.-F.; CHING-HUNG LIN; Kuo C.-H.; Chen W.-W.; Yeh D.-C.; Liao H.-W.; Huang S.-M.; Cheng A.-L.; Lu Y.-S. |
